These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16902972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW, Baseman A, Assikis V, Zhau HE.
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [Abstract] [Full Text] [Related]

  • 3. [Epithelial-mesenchymal transition in cancer progression].
    Gos M, Miłoszewska J, Przybyszewska M.
    Postepy Biochem; 2009 Jan; 55(2):121-8. PubMed ID: 19824467
    [Abstract] [Full Text] [Related]

  • 4. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
    Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, Marshall FF, Zhau HE, Chung LW.
    Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
    [Abstract] [Full Text] [Related]

  • 5. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
    Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED.
    Cancer Res; 2006 Dec 01; 66(23):11271-8. PubMed ID: 17145872
    [Abstract] [Full Text] [Related]

  • 7. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
    Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y, Zhu G, Yang L, Wang X, He D.
    Oncol Rep; 2010 Jun 01; 23(6):1545-52. PubMed ID: 20428808
    [Abstract] [Full Text] [Related]

  • 8. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
    Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, Chu G, Liu ZR, Zhou BP, Huang WC, Chung LW.
    Clin Exp Metastasis; 2008 Sep 15; 25(6):601-10. PubMed ID: 18535913
    [Abstract] [Full Text] [Related]

  • 11. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW.
    Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717
    [Abstract] [Full Text] [Related]

  • 12. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
    Liu CY, Chao TK, Su PH, Lee HY, Shih YL, Su HY, Chu TY, Yu MH, Lin YW, Lai HC.
    J Pathol; 2009 Oct 03; 219(2):222-31. PubMed ID: 19644956
    [Abstract] [Full Text] [Related]

  • 13. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC.
    Prostate; 2008 Jan 01; 68(1):92-104. PubMed ID: 18008334
    [Abstract] [Full Text] [Related]

  • 14. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
    Hall CL, Dai J, van Golen KL, Keller ET, Long MW.
    Cancer Res; 2006 Sep 01; 66(17):8648-54. PubMed ID: 16951179
    [Abstract] [Full Text] [Related]

  • 15. In vivo models of prostate cancer metastasis to bone.
    Singh AS, Figg WD.
    J Urol; 2005 Sep 01; 174(3):820-6. PubMed ID: 16093963
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.
    Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L, Chiarugi P.
    Cancer Res; 2010 Sep 01; 70(17):6945-56. PubMed ID: 20699369
    [Abstract] [Full Text] [Related]

  • 19. Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity.
    Jennbacken K, Gustavsson H, Welén K, Vallbo C, Damber JE.
    Prostate; 2006 Nov 01; 66(15):1631-40. PubMed ID: 16927303
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.